Evidence map›Paper›PMID 37982634›Full record

ArticleMicrobiology spectrum2023

Marguerite L Monogue, Dhara Desai, Christine A Pybus, James M Sanders, Andrew E Clark, David E Greenberg

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marguerite L MonogueDepartment of Pharmacy, University of Texas Southwestern Medical Center , Dallas, Texas, USA.ORCID 0000-0001-8251-458X
Dhara DesaiDepartment of Microbiology, University of Texas Southwestern Medical Center , Dallas, Texas, USA.
Christine A PybusDepartment of Microbiology, University of Texas Southwestern Medical Center , Dallas, Texas, USA.
James M SandersDepartment of Pharmacy, University of Texas Southwestern Medical Center , Dallas, Texas, USA.
Andrew E ClarkDepartment of Pathology, University of Texas Southwestern Medical Center , Dallas, Texas, USA.
David E GreenbergDepartment of Internal Medicine, Infectious Diseases, and Geographic Medicine, University of Texas Southwestern Medical Center , Dallas, Texas, USA.ORCID 0000-0002-5101-3106

Funding

Shionogi (Shionogi & Co. Ltd.) SRA202111-0005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisPseudomonas InfectionsAnti-Bacterial AgentsCefiderocolCephalosporinsHumansMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsCefiderocolCephalosporinscefiderocolcystic fibrosisin vitroPseudomonas aeruginosa

Identifiers

PMID37982634
PMCPMC10714955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.